Frontlight ResearchEarly access
Spinal cord injury trials in Lithuania
1 trial · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleOpen-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
- Where
- Kaunas, Vilnius
- Age
- 2 years to 17 years
- People
- 71 worldwide
- Run by
- Urovant Sciences GmbH
See details and how to joinNCT05491525